These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
N6-methyladenosine (m6A) deposition by METTL3 at specific sites within lncRNA-0021 (positions 180-220) recruits the YTHDF2 reader protein, which orchestrates a conformational change that exposes the miR-6361 binding site. In AD, reduced METTL3 activity leads to lncRNA-0021 hypermethylation or hypomethylation, either occluding the miR-6361 seed match or destabilizing the transcript. Therapeutic approaches using METTL3 activators or engineered m6A-modified lncRNA mimics could restore optimal miR-6361 sequestration and normalize downstream ceRNA networks.
No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.439 | ▼ 12.5% | evidence_update | 2026-04-17 01:10 |
| 📄 | New Evidence | $0.502 | ▲ 11.5% | evidence_update | 2026-04-17 01:10 |
| ✨ | Listed | $0.450 | post_process | 2026-04-17 01:10 |
No clinical trials data available
No knowledge graph edges recorded